Visceral Fat and Metabolic Syndrome Risk
Table of Contents
Introduction
A common question in the clinic: "My weight is normal, but an abdominal CT showed high visceral fat. Is that a problem?" We frequently encounter patients whose BMI falls within the normal range yet have excessive visceral fat. Many of them already show metabolic abnormalities or carry a high risk of progressing to metabolic syndrome.
Clinical Observations
This condition is often called sarcopenic obesity. The body appears normal externally, but abdominal CT or DEXA measurements reveal visceral fat area exceeding 100 cm². These patients often think "at least I'm not overweight," yet their blood tests frequently show elevated triglycerides, decreased HDL cholesterol, and elevated fasting glucose.
Mechanism and Causes
Visceral fat is not merely an energy storage depot. It is a metabolically active adipose tissue that secretes various hormones and cytokines, making it the body's largest endocrine organ.
When visceral fat increases, the following changes occur:
1. Increased Insulin Resistance
Free fatty acids flow directly into the liver, disrupting insulin signal transduction in hepatocytes. This can lead to a spectrum of metabolic abnormalities ranging from reactive hypoglycemia to type 2 diabetes.
2. Chronic Low-Grade Inflammation
Visceral fat excessively secretes inflammatory cytokines such as TNF-alpha and IL-6. This chronic low-grade inflammation worsens systemic insulin resistance and promotes vascular wall inflammation.
3. Decreased Adiponectin
As visceral fat increases, blood adiponectin levels decrease. Adiponectin is a protective hormone that enhances insulin sensitivity and suppresses inflammation.
Key references include Matsuzawa et al.'s research on visceral fat and metabolic syndrome, and Després's discussion on the obesity paradox.
Practical Application
In the clinic, we approach this as follows:
Measurement: BMI alone is insufficient. We measure waist circumference (risk threshold: 90 cm for men, 85 cm for women) and, when possible, use bioimpedance for body composition analysis.
Counseling: We clearly communicate that "even lean obesity is not an exception." We help patients understand that normal weight does not guarantee good health.
Intervention: Lifestyle modification takes priority over medication. We design exercise prescriptions that maintain muscle mass while reducing visceral fat. Combining resistance training with aerobic exercise has proven most effective.
Conclusion
Lean obesity is not an exception. Since decreased muscle mass and increased visceral fat often coexist, metabolic risk assessment through waist circumference and body composition analysis is necessary even with normal weight.
(Limitations: This article is primarily based on cross-sectional studies and epidemiological observations, with considerable individual variation. Specific treatment plans should be tailored to each patient's clinical context.)
